AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 281 min read$MMSI

Merit Medical Systems (MMSI) reports earnings tomorrow: what to expect

Merit Medical Systems (MMSI) will report earnings on Thursday. Last quarter, it beat revenue expectations with $418.8M, up 9.5% YoY. Analysts expect 6.8% YoY revenue growth this quarter. The stock is up 7.5% over the last month, with an average price target of $101.64.

Original reporting
tradingview.com
Published Oct 28, 2026, 3:29 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 3:56 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Merit Medical Systems (MMSI) reports earnings tomorrow: what to expect — source image
Source · tradingview.com
Decision brief

The 30-second read

$MMSINeutralLow
01

Why it matters

The preview sets expectations but provides no new data; traders may position ahead of the earnings release.

02

Market read

Pre-earnings coverage with modest relevance; primarily of interest to healthcare sector investors.

03

What to watch

Potential supply-chain issues or regulatory changes that could affect Q4 performance.

Relevance 4/10Novelty 2/10Timing: before earnings Thursday

Background

Merit Medical Systems (MMSI) is a medical device maker that recently beat revenue expectations and is slated to report earnings Thursday.

Company-level read

Ticker impact

$MMSINeutralMedium confidence
Context

The article previews Merit Medical Systems' upcoming earnings, noting prior revenue beat and analyst expectations.

Expected impact

potential price swing around the earnings announcement

Evidence & confidence

Investors will react to the actual results versus the previewed expectations.

Market effects

Sector

Limited; only affects the medical device sector if results deviate from expectations.

Regional

U.S. market focus on the healthcare equipment segment.

Global

Low; primarily relevant to investors in Merit Medical Systems.

Counterpoint

What could challenge this read

If the company misses expectations, the stock could see a sharp decline despite the preview optimism.

Key entities

  • company
    Merit Medical Systems

    Medical device manufacturer reporting earnings.

Read at source← All news

Related articles

AUG 12
$MMSIMedAI 8/10

Merit Medical Systems (MMSI) Is Up 6.2% After Raising 2026 Outlook And Q2 Beat Expectations – Has The Bull Case Changed?

Merit Medical Systems (MMSI) reported Q2 2026 sales of $418.84 million and net income of $38.8 million, and raised its full-year 2026 revenue outlook to $1.63 billion to $1.64 billion, according to the company. The article notes ongoing product recalls and reimbursement risks and mentions a 2029 narrative of about $1.8 billion revenue and $213.7 million earnings.

simplywall.st6 min
AUG 9
$MMSIMedAI 8/10

Merit Medical (MMSI) Q2 2026 Earnings Call Transcript

Merit Medical Systems (MMSI) reported Q2 2026 revenue of $418.8 million, up 10% GAAP, and non-GAAP EPS of $1.19. Non-GAAP operating margin was 22.6% and free cash flow $51.9 million. The company raised 2026 revenue guidance to $1.631B-$1.643B and non-GAAP EPS to $4.25-$4.35, and guided Q3 revenue to $408M-$413M.

aol.com6 min
AUG 8
$MMSIMedAI 8/10

Merit Medical (MMSI) Q2 2026 Earnings Call Transcript

Merit Medical Systems (MMSI) reported Q2 2026 revenue of $418.8 million, up 10% GAAP, and non-GAAP EPS of $1.19. Non-GAAP operating margin was 22.6% and free cash flow $51.9 million. The company raised 2026 revenue guidance to $1.631B-$1.643B and non-GAAP EPS to $4.25-$4.35, and guided Q3 revenue to $408M-$413M.

fool.com6 min
JUL 31
$MMSIMedAI 8/10

These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results - Merit Medical

Merit Medical Systems Inc (NASDAQ:MMSI) posted better-than-expected earnings for the second quarter on Thursday. The company posted adjusted EPS of $1.19, beating market estimates of 96 cents per share. The company’s sales came in at $418.843 million versus expectations of $405.268 million. Merit Medical Systems raised its FY2026 adjusted EPS guidance from $4.01-$4.15 to $4.25-$4.35 and increased its sales forecast from $1.612 billion-$1.634 billion to $1.631 billion-$1.643 billion.

benzinga.com3 min
JUL 30
$MMSIMedAI 8/10

Merit Medical Systems (NASDAQ:MMSI) Reports Bullish Q2 CY2026, Stock Soars

Medical device company Merit Medical Systems (NASDAQ: MMSI) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 9.5% year on year to $418.8 million. The company’s full-year revenue guidance of $1.64 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.19 per share was 24% above analysts’ consensus estimates. Is now the time to buy Merit Medical Systems? Find out by accessing our full research report, it’s free.

financialcontent.com4 min